No. We offer telehealth visits for any client who is not prescribed a controlled substances.
For those who need controlled substances, it is important to know:
Under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the Ryan Haight Act), a prescribing practitioner—subject to certain exceptions—may prescribe controlled medications to a patient only after conducting an in-person evaluation of that patient. In response to the COVID–19, as declared by the Secretary of the Department of Health and Human Services on January 31, 2020, pursuant to the authority under section 319 of the Public Health Service Act (42 U.S.C. 247), the Drug Enforcement Administration (DEA) granted temporary exceptions to the Ryan Haight Act and DEA's implementing regulations under 21 U.S.C. 802(54)(D), thereby allowing the prescribing of controlled medications via telemedicine encounters—even when the prescribing practitioner had not conducted an in-person medical evaluation of the patient—in order to prevent lapses in care.
At this time, a Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications was granted. Meaning patients receiving controlled substances, like Adderall for ADHD, may also be seeing via a telehealth visit without the mandate of an in-person visit.
This rule is effective May 11, 2023, through November 11, 2024.
*The convenience of telehealth is important as it reduces the occurrence of gaps in care. However, the extension described above does not mean you will not be asked to attend in-person visits from time to time. The extension means there's no current legal requirement to be seen in person prior to prescribing or refilling a controlled substance. Client safety is our priority, and the convenience of telehealth may not always be feasible or appropriate.
**Please not the pharmacies may still decide to decline to fill your prescription based on their individually company policies.